BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9891464)

  • 1. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Alexiou D; Kalahanis N; Rosenberg T; Bastounis E
    Anticancer Res; 1998; 18(6A):4177-80. PubMed ID: 9891464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage.
    Pignatelli M; Ansari TW; Gunter P; Liu D; Hirano S; Takeichi M; Klöppel G; Lemoine NR
    J Pathol; 1994 Dec; 174(4):243-8. PubMed ID: 7884585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin expression as a differentiation marker in gastric cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
    Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
    Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
    Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
    Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
    J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin expression correlates with tumor differentiation in colorectal cancer.
    Karatzas G; Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Riza F; Papanikolaou D
    Hepatogastroenterology; 1999; 46(25):232-5. PubMed ID: 10228798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
    Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
    Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between expressions of E-cadherin and alpha-catenin and biological behaviors of human pancreatic cancer.
    Li YJ; Meng YX; Ji XR
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):471-7. PubMed ID: 14599963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
    Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
    Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
    Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
    Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
    Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
    Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA
    Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between decreased expression of squamous cell carcinoma antigen 2 and E-cadherin in primary cervical cancer lesions and lymph node metastasis.
    Murakami A; Nakagawa T; Fukushima C; Torii M; Sueoka K; Nawata S; Takeda O; Ishikawa H; Sugino N
    Oncol Rep; 2008 Jan; 19(1):99-104. PubMed ID: 18097581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis.
    Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H
    Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.
    Schipper JH; Frixen UH; Behrens J; Unger A; Jahnke K; Birchmeier W
    Cancer Res; 1991 Dec; 51(23 Pt 1):6328-37. PubMed ID: 1933895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor, matrix metalloproteinase-9 and E-cadherin in the process of lymph node metastasis in oesophageal cancer.
    Sato F; Shimada Y; Watanabe G; Uchida S; Makino T; Imamura M
    Br J Cancer; 1999 Jul; 80(9):1366-72. PubMed ID: 10424737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.